登录 | 注册    关注公众号  
微信公众号
搜索
 > 【B7-H6】

抗体项目交易平台

项目名称 项目阶段 分子类型 分子来源 疾病领域 适应症
B7H6&CD3 BsAb - 01 PCC 双抗 鼠源人源化,纳米抗体 实体瘤 肺癌,结直肠癌
B7H6 mAb - 01 PCC 单抗 鼠源人源化 实体瘤 小细胞肺癌,结直肠癌

B7-H6产品列表

ACRO质量管理体系
 
评论(17)
B76-C52Ha|Cynomolgus B7-H6 / NCR3LG1 Protein, His Tag
  1. 198XXXXXXX5
  2. 2人赞
  3. 在同事推荐下,购买了ACRO BIOSYSTEMS家的B76-C52Ha蛋白产品,用于做ELISA实验,非常棒!!
  4. 2022-09-26
B76-C52Ha|Cynomolgus B7-H6 / NCR3LG1 Protein, His Tag
  1. 139XXXXXXX8
  2. 0人赞
  3. 在抗体筛选工作中用到该蛋白,进行了一系列实验条件摸索,抗原蛋白方便溶解与包,很适合初次实验者使用。所提供的技术支持体系也相当完善,面对试验中遇到的任何问题,都能从多个角度给予及时且有效的支持与解决方案。
  4. 2024-10-31
B76-C52Ha|Cynomolgus B7-H6 / NCR3LG1 Protein, His Tag
  1. 199XXXXXXX5
  2. 0人赞
  3. 采购该货号猴B7H6蛋白主要用于全合成抗体库的筛选工作,在原材料验证时同时拿其他品牌蛋白做了对照,发现acro的蛋白质量数据稳定性明显高于其他同行产品,性价比也高,很值得推荐!
  4. 2024-02-04
 

B7-H6分子别名

B7-H6,NCR3LG1,B7 Homolog 6

B7-H6分子背景

The B7 family of genes is essential in the regulation of the adaptive immune system. one of which is the recently discovered B7H6. Humans and rats have a single B7H6 gene; however, many B7H6 genes were detected in a single large cluster in the Xenopus genome.
Chimeric antigen receptor (CAR) T-cell therapies have demonstrated durable and potentially curative therapeutic efficacy against B-cell leukemia in clinical trials. In this study, B7H6, a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.

消息提示

请输入您的联系方式,再点击提交!

确定